OREANDA-NEWS. On 19 September 2007, OKO Bank plc will issue an equity basket bond, OKO Pharma-Obligaatio VI/2007, with a maximum nominal volume of EUR 20 million. The maturity of the bond is four years and it is targeted at retail investors. The bond will be issued under OKO Bank's domestic bond programme. Its subscription period will begin on 13 August 2007, reported the press-centre of OKO Bank.

The bond alternatives are Neutral and Plus with issue prices of 100% and 110%.
The index-linked yield is calculated by multiplying the relative positive change between the initial and final value of the equity basket formed by company shares, using a participation rate.

The companies included in the equity basket are: Astella Pharma Inc, Bristol-Myers Squibb Company, GlaxoSmithKline Plc, Novartis International AG, Orion Corporation, Pfizer Inc, Roche Holding Ltd and Takeda Pharmaceutical Co Ltd.

 The manager of the issue is OKO Bank and the bond will be listed on the OMX Nordic Exchange Helsinki provided that subscriptions exceed EUR 2,000,000. The subscription agents are the offices of the member banks of the OP Bank Group and the Group's telephone service 0100 0500. Subscriptions can also be made on the Group's and OKO Bank's websites.